CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | Korenberg Matthew E EVP,Finance & Strategy and CFO | Other acquisition | +247 | $85.91 | $21K | 39,690 |
| 2021-06-04 | Sabba Stephen L Director | Grant or award | +630 | 25,061 | ||
| 2021-06-04 | Sabba Stephen L Director | Grant or award · Non-Qualified Stock Option (right to buy) | −3,269 | 3,269 | ||
| 2021-06-04 | Aryeh Jason Director | Grant or award | +630 | 68,664 | ||
| 2021-06-04 | Aryeh Jason Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-06-04 | Boyce Sarah Director | Grant or award | +630 | 2,892 | ||
| 2021-06-04 | Boyce Sarah Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-06-04 | Davis Todd C Director | Grant or award | +630 | 50,782 | ||
| 2021-06-04 | Davis Todd C Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-06-04 | Gray Nancy Ryan Director | Grant or award | +630 | 3,702 | ||
| 2021-06-04 | Gray Nancy Ryan Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-06-04 | KOZARICH JOHN W Director | Grant or award | +630 | 34,782 | ||
| 2021-06-04 | KOZARICH JOHN W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-06-04 | LAMATTINA JOHN L Director | Grant or award | +630 | 25,398 | ||
| 2021-06-04 | LAMATTINA JOHN L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-06-04 | Patel Sunil Director | Grant or award | +630 | 28,820 | ||
| 2021-06-04 | Patel Sunil Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,269 | 3,269 | ||
| 2021-05-28 | FOEHR MATTHEW W President and COO | Gift | −2,500 | 162,600 | ||
| 2021-05-28 | FOEHR MATTHEW W President and COO | Option exercise | +1,755 | $56.26 | $99K | 164,355 |
| 2021-05-28 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −1,755 | 40,358 |
Page 33 of 43 · 858 trades